Maintenance of Smoking Cessation Clinical Trial
Official title:
Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Maintenance of Smoking Cessation (1-Year Treatment, 1-Year Follow-up)
The primary study objective is to evaluate the efficacy of 2 dose levels of rimonabant (5 mg
and 20 mg) for the maintenance of abstinence from smoking.
Secondary objectives are to evaluate the effect of rimonabant on craving and weight, the
clinical and biological safety of 2 doses of rimonabant rimonabant during a 12-month
treatment period and to evaluate the pharmacokinetics of the drug.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment